{
  "id": 20282744,
  "title": "CG Oncology's bladder cancer treatment beats expectations in Phase 3",
  "url": "https://urgent.news/2026/11/16/cg-oncologys-bladder-cancer-treatment-beats-expectations-in-phase-3",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-16T13:00:01.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/cg-oncologys-bladder-cancer-treatment-beats-expectations-in-phase-3/"
  },
  "original_language": "en",
  "account": null,
  "summary": "CG Oncology said its oncolytic immunotherapy succeeded in a late-stage trial in certain patients with non-muscle invasive bladder cancer, potentially expanding the asset’s market significantly. Cretostimogene grenadenorepvec met the Phase 3 ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}